ROLE SUMMARY
Bring strong scientific and communication skills, along with industry knowledge, to support Head of Scientific Affairs & Strategic Partnerships and Pfizer Oncology Leadership Team (LT) in providing senior-level scientific, strategic ...
UCSD Layoff from Career Appointment : Apply by 02/12/2024 for consideration with preference for rehire. All layoff applicants should contact their Employment Advisor.
Special Selection Applicants : Apply by 02/21/2024. Eligible Special Selectio...
Job Title: Director, Scientific Communications
Reporting To: VP, Medical Affairs
Department : Medical Affairs
People Manage r: No
Location: Remote or La Jolla, CA Hybrid (2-3 days a week in office)
Position Summary
The Director...
UCSD Layoff from Career Appointment : Apply by 1/26/2024 for consideration with preference for rehire. All layoff applicants should contact their Employment Advisor.
Special Selection Applicants : Apply by 2/07/2024. Eligible Special Selection ...
UCSD Layoff from Career Appointment : Apply by 2/28/24 for consideration with preference for rehire. All layoff applicants should contact their Employment Advisor.
Special Selection Applicants : Apply by 3/8/24. Eligible Special Selection clien...
UCSD Layoff from Career Appointment : Apply by 01/16/2024 for consideration with preference for rehire. All layoff applicants should contact their Employment Advisor.
Special Selection Applicants : Apply by 01/25/2024. Eligible Special Selectio...
ROLE SUMMARY
The Global & US Medical Content Lead will plan and deliver an end-to-end medical channel content strategy across Pfizer medicines and therapeutic areas to optimize the engagement and reach of emerging scientific information.
ROLE ...
UCSD Layoff from Career Appointment : Apply by 02/12/2024 for consideration with preference for rehire. All layoff applicants should contact their Employment Advisor.
Special Selection Applicants : Apply by 02/21/2024. Eligible Special Selectio...
ROLE SUMMARY
Today, Pfizer Oncology has an industry-leading portfolio of 25 approved innovative cancer medicines, including major therapies for metastatic breast cancer, prostate cancer, urothelial carcinoma and haemato-oncological malignancies. ...
Today, Pfizer Oncology has an industry-leading portfolio of 25 approved innovative cancer medicines, including major therapies for metastatic breast cancer, prostate cancer, urothelial carcinoma and haemato-oncological malignancies. Pfizer's in-line ...
